Code
stringlengths
3
7
Description
stringlengths
4
228
T467X3D
Poisoning by peripheral vasodilators, assault, subsequent encounter
T467X3S
Poisoning by peripheral vasodilators, assault, sequela
T467X4A
Poisoning by peripheral vasodilators, undetermined, initial encounter
T467X4D
Poisoning by peripheral vasodilators, undetermined, subsequent encounter
T467X4S
Poisoning by peripheral vasodilators, undetermined, sequela
T467X5A
Adverse effect of peripheral vasodilators, initial encounter
T467X5D
Adverse effect of peripheral vasodilators, subsequent encounter
T467X5S
Adverse effect of peripheral vasodilators, sequela
T467X6A
Underdosing of peripheral vasodilators, initial encounter
T467X6D
Underdosing of peripheral vasodilators, subsequent encounter
T467X6S
Underdosing of peripheral vasodilators, sequela
T468X1A
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
T468X1D
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter
T468X1S
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela
T468X2A
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
T468X2D
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter
T468X2S
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela
T468X3A
Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
T468X3D
Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter
T468X3S
Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela
T468X4A
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
T468X4D
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter
T468X4S
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
T468X5A
Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
T468X5D
Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
T468X5S
Adverse effect of antivaricose drugs, including sclerosing agents, sequela
T468X6A
Underdosing of antivaricose drugs, including sclerosing agents, initial encounter
T468X6D
Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
T468X6S
Underdosing of antivaricose drugs, including sclerosing agents, sequela
T46901A
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46901D
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
T46901S
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
T46902A
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
T46902D
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
T46902S
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela
T46903A
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
T46903D
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter
T46903S
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela
T46904A
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
T46904D
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
T46904S
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela
T46905A
Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
T46905D
Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
T46905S
Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
T46906A
Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter
T46906D
Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
T46906S
Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela
T46991A
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46991D
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
T46991S
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
T46992A
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
T46992D
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
T46992S
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela
T46993A
Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
T46993D
Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter
T46993S
Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela
T46994A
Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
T46994D
Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
T46994S
Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela
T46995A
Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
T46995D
Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
T46995S
Adverse effect of other agents primarily affecting the cardiovascular system, sequela
T46996A
Underdosing of other agents primarily affecting the cardiovascular system, initial encounter
T46996D
Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
T46996S
Underdosing of other agents primarily affecting the cardiovascular system, sequela
T470X1A
Poisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter
T470X1D
Poisoning by histamine H2-receptor blockers, accidental (unintentional), subsequent encounter
T470X1S
Poisoning by histamine H2-receptor blockers, accidental (unintentional), sequela
T470X2A
Poisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter
T470X2D
Poisoning by histamine H2-receptor blockers, intentional self-harm, subsequent encounter
T470X2S
Poisoning by histamine H2-receptor blockers, intentional self-harm, sequela
T470X3A
Poisoning by histamine H2-receptor blockers, assault, initial encounter
T470X3D
Poisoning by histamine H2-receptor blockers, assault, subsequent encounter
T470X3S
Poisoning by histamine H2-receptor blockers, assault, sequela
T470X4A
Poisoning by histamine H2-receptor blockers, undetermined, initial encounter
T470X4D
Poisoning by histamine H2-receptor blockers, undetermined, subsequent encounter
T470X4S
Poisoning by histamine H2-receptor blockers, undetermined, sequela
T470X5A
Adverse effect of histamine H2-receptor blockers, initial encounter
T470X5D
Adverse effect of histamine H2-receptor blockers, subsequent encounter
T470X5S
Adverse effect of histamine H2-receptor blockers, sequela
T470X6A
Underdosing of histamine H2-receptor blockers, initial encounter
T470X6D
Underdosing of histamine H2-receptor blockers, subsequent encounter
T470X6S
Underdosing of histamine H2-receptor blockers, sequela
T471X1A
Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter
T471X1D
Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), subsequent encounter
T471X1S
Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela
T471X2A
Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter
T471X2D
Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, subsequent encounter
T471X2S
Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela
T471X3A
Poisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter
T471X3D
Poisoning by other antacids and anti-gastric-secretion drugs, assault, subsequent encounter
T471X3S
Poisoning by other antacids and anti-gastric-secretion drugs, assault, sequela
T471X4A
Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter
T471X4D
Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, subsequent encounter
T471X4S
Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, sequela
T471X5A
Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
T471X5D
Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
T471X5S
Adverse effect of other antacids and anti-gastric-secretion drugs, sequela
T471X6A
Underdosing of other antacids and anti-gastric-secretion drugs, initial encounter
T471X6D
Underdosing of other antacids and anti-gastric-secretion drugs, subsequent encounter